Global Loratadine Syrup Market

Loratadine Syrup Comprehensive Study by Application (Runny nose & Sneezing, Itchy, watery eyes, Itching of the nose or throat), End User (Adults and Children 6 years of age and above, Children 2 to under 6 years of age) Players and Region - Global Market Outlook to 2030

Loratadine Syrup Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Loratadine Syrup
Loratadine is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms. Loratadine is also used to treat skin hives and itching in people with chronic skin reactions.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Loratadine Syrup market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bayer AG (Germany), Taro Pharmaceutical Industries Ltd. (United States), Teva Pharmaceutical (Israel), Merck & Co., Inc. (United States), Bayer AG (Germany), Sun Pharma (India), Pfizer (United States) and Mylan (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Sandoz (Switzerland), Apotex (Canada) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Loratadine Syrup market by , Application (Runny nose & Sneezing, Itchy, watery eyes and Itching of the nose or throat) and Region.



On the basis of geography, the market of Loratadine Syrup has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Adults and Children 6 years of age and above will boost the Loratadine Syrup market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Continuous Development in Loratadine Drugs

Market Growth Drivers:
Growing Burden of Allergies Around the World and Growing Adaptation of Loratadine and Active Pipelines

Challenges:
Stringent Regulatory Policies

Restraints:
Availability of Alternatives Form such as Tablet and Capsule

Opportunities:
Growing Adaptation of Loratadine and Active Pipelines and Rising R&D Initiatives to Test the Various Combinations of Loratadine in the Treatment of Diseases

In May 2021, Bayer Launched Children’s Loratadine Syrup In Time For UK Hay Fever Season. Bayer Consumer Health adds a children's loratadine-based syrup to its UK Clarityn hay fever brand.


Key Target Audience
Loratadine Syrup Manufacturers, Loratadine syrup Suppliers, Medical Research Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers, Potential Investors and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Runny nose & Sneezing
  • Itchy, watery eyes
  • Itching of the nose or throat
By End User
  • Adults and Children 6 years of age and above
  • Children 2 to under 6 years of age

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Burden of Allergies Around the World
      • 3.2.2. Growing Adaptation of Loratadine and Active Pipelines
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Policies
    • 3.4. Market Trends
      • 3.4.1. Continuous Development in Loratadine Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Loratadine Syrup, by Application, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Loratadine Syrup (Value)
      • 5.2.1. Global Loratadine Syrup by: Application (Value)
        • 5.2.1.1. Runny nose & Sneezing
        • 5.2.1.2. Itchy, watery eyes
        • 5.2.1.3. Itching of the nose or throat
      • 5.2.2. Global Loratadine Syrup by: End User (Value)
        • 5.2.2.1. Adults and Children 6 years of age and above
        • 5.2.2.2. Children 2 to under 6 years of age
      • 5.2.3. Global Loratadine Syrup Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Loratadine Syrup (Volume)
      • 5.3.1. Global Loratadine Syrup by: Application (Volume)
        • 5.3.1.1. Runny nose & Sneezing
        • 5.3.1.2. Itchy, watery eyes
        • 5.3.1.3. Itching of the nose or throat
      • 5.3.2. Global Loratadine Syrup by: End User (Volume)
        • 5.3.2.1. Adults and Children 6 years of age and above
        • 5.3.2.2. Children 2 to under 6 years of age
      • 5.3.3. Global Loratadine Syrup Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Loratadine Syrup (Price)
  • 6. Loratadine Syrup: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Taro Pharmaceutical Industries Ltd. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceutical (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co., Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sun Pharma (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mylan (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Loratadine Syrup Sale, by Application, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Loratadine Syrup (Value)
      • 7.2.1. Global Loratadine Syrup by: Application (Value)
        • 7.2.1.1. Runny nose & Sneezing
        • 7.2.1.2. Itchy, watery eyes
        • 7.2.1.3. Itching of the nose or throat
      • 7.2.2. Global Loratadine Syrup by: End User (Value)
        • 7.2.2.1. Adults and Children 6 years of age and above
        • 7.2.2.2. Children 2 to under 6 years of age
      • 7.2.3. Global Loratadine Syrup Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Loratadine Syrup (Volume)
      • 7.3.1. Global Loratadine Syrup by: Application (Volume)
        • 7.3.1.1. Runny nose & Sneezing
        • 7.3.1.2. Itchy, watery eyes
        • 7.3.1.3. Itching of the nose or throat
      • 7.3.2. Global Loratadine Syrup by: End User (Volume)
        • 7.3.2.1. Adults and Children 6 years of age and above
        • 7.3.2.2. Children 2 to under 6 years of age
      • 7.3.3. Global Loratadine Syrup Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Loratadine Syrup (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Loratadine Syrup: by Application(USD Million)
  • Table 2. Loratadine Syrup Runny nose & Sneezing , by Region USD Million (2018-2023)
  • Table 3. Loratadine Syrup Itchy, watery eyes , by Region USD Million (2018-2023)
  • Table 4. Loratadine Syrup Itching of the nose or throat , by Region USD Million (2018-2023)
  • Table 5. Loratadine Syrup: by End User(USD Million)
  • Table 6. Loratadine Syrup Adults and Children 6 years of age and above , by Region USD Million (2018-2023)
  • Table 7. Loratadine Syrup Children 2 to under 6 years of age , by Region USD Million (2018-2023)
  • Table 8. South America Loratadine Syrup, by Country USD Million (2018-2023)
  • Table 9. South America Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 10. South America Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 11. Brazil Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 12. Brazil Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 13. Argentina Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 14. Argentina Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 15. Rest of South America Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 16. Rest of South America Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 17. Asia Pacific Loratadine Syrup, by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 19. Asia Pacific Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 20. China Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 21. China Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 22. Japan Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 23. Japan Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 24. India Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 25. India Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 26. South Korea Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 27. South Korea Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 28. Taiwan Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 29. Taiwan Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 30. Australia Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 31. Australia Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 34. Europe Loratadine Syrup, by Country USD Million (2018-2023)
  • Table 35. Europe Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 36. Europe Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 37. Germany Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 38. Germany Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 39. France Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 40. France Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 41. Italy Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 42. Italy Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 43. United Kingdom Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 44. United Kingdom Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 45. Netherlands Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 46. Netherlands Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 47. Rest of Europe Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 48. Rest of Europe Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 49. MEA Loratadine Syrup, by Country USD Million (2018-2023)
  • Table 50. MEA Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 51. MEA Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 52. Middle East Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 53. Middle East Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 54. Africa Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 55. Africa Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 56. North America Loratadine Syrup, by Country USD Million (2018-2023)
  • Table 57. North America Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 58. North America Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 59. United States Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 60. United States Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 61. Canada Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 62. Canada Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 63. Mexico Loratadine Syrup, by Application USD Million (2018-2023)
  • Table 64. Mexico Loratadine Syrup, by End User USD Million (2018-2023)
  • Table 65. Loratadine Syrup Sales: by Application(K Unit)
  • Table 66. Loratadine Syrup Sales Runny nose & Sneezing , by Region K Unit (2018-2023)
  • Table 67. Loratadine Syrup Sales Itchy, watery eyes , by Region K Unit (2018-2023)
  • Table 68. Loratadine Syrup Sales Itching of the nose or throat , by Region K Unit (2018-2023)
  • Table 69. Loratadine Syrup Sales: by End User(K Unit)
  • Table 70. Loratadine Syrup Sales Adults and Children 6 years of age and above , by Region K Unit (2018-2023)
  • Table 71. Loratadine Syrup Sales Children 2 to under 6 years of age , by Region K Unit (2018-2023)
  • Table 72. South America Loratadine Syrup Sales, by Country K Unit (2018-2023)
  • Table 73. South America Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 74. South America Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 75. Brazil Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 76. Brazil Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 77. Argentina Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 78. Argentina Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 79. Rest of South America Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 80. Rest of South America Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 81. Asia Pacific Loratadine Syrup Sales, by Country K Unit (2018-2023)
  • Table 82. Asia Pacific Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 83. Asia Pacific Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 84. China Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 85. China Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 86. Japan Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 87. Japan Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 88. India Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 89. India Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 90. South Korea Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 91. South Korea Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 92. Taiwan Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 93. Taiwan Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 94. Australia Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 95. Australia Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 96. Rest of Asia-Pacific Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 97. Rest of Asia-Pacific Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 98. Europe Loratadine Syrup Sales, by Country K Unit (2018-2023)
  • Table 99. Europe Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 100. Europe Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 101. Germany Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 102. Germany Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 103. France Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 104. France Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 105. Italy Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 106. Italy Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 107. United Kingdom Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 108. United Kingdom Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 109. Netherlands Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 110. Netherlands Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 111. Rest of Europe Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 112. Rest of Europe Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 113. MEA Loratadine Syrup Sales, by Country K Unit (2018-2023)
  • Table 114. MEA Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 115. MEA Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 116. Middle East Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 117. Middle East Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 118. Africa Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 119. Africa Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 120. North America Loratadine Syrup Sales, by Country K Unit (2018-2023)
  • Table 121. North America Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 122. North America Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 123. United States Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 124. United States Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 125. Canada Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 126. Canada Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 127. Mexico Loratadine Syrup Sales, by Application K Unit (2018-2023)
  • Table 128. Mexico Loratadine Syrup Sales, by End User K Unit (2018-2023)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Loratadine Syrup: by Application(USD Million)
  • Table 138. Loratadine Syrup Runny nose & Sneezing , by Region USD Million (2025-2030)
  • Table 139. Loratadine Syrup Itchy, watery eyes , by Region USD Million (2025-2030)
  • Table 140. Loratadine Syrup Itching of the nose or throat , by Region USD Million (2025-2030)
  • Table 141. Loratadine Syrup: by End User(USD Million)
  • Table 142. Loratadine Syrup Adults and Children 6 years of age and above , by Region USD Million (2025-2030)
  • Table 143. Loratadine Syrup Children 2 to under 6 years of age , by Region USD Million (2025-2030)
  • Table 144. South America Loratadine Syrup, by Country USD Million (2025-2030)
  • Table 145. South America Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 146. South America Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 147. Brazil Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 148. Brazil Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 149. Argentina Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 150. Argentina Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 151. Rest of South America Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 152. Rest of South America Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 153. Asia Pacific Loratadine Syrup, by Country USD Million (2025-2030)
  • Table 154. Asia Pacific Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 155. Asia Pacific Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 156. China Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 157. China Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 158. Japan Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 159. Japan Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 160. India Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 161. India Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 162. South Korea Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 163. South Korea Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 164. Taiwan Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 165. Taiwan Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 166. Australia Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 167. Australia Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 168. Rest of Asia-Pacific Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 169. Rest of Asia-Pacific Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 170. Europe Loratadine Syrup, by Country USD Million (2025-2030)
  • Table 171. Europe Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 172. Europe Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 173. Germany Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 174. Germany Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 175. France Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 176. France Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 177. Italy Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 178. Italy Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 179. United Kingdom Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 180. United Kingdom Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 181. Netherlands Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 182. Netherlands Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 183. Rest of Europe Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 184. Rest of Europe Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 185. MEA Loratadine Syrup, by Country USD Million (2025-2030)
  • Table 186. MEA Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 187. MEA Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 188. Middle East Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 189. Middle East Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 190. Africa Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 191. Africa Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 192. North America Loratadine Syrup, by Country USD Million (2025-2030)
  • Table 193. North America Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 194. North America Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 195. United States Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 196. United States Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 197. Canada Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 198. Canada Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 199. Mexico Loratadine Syrup, by Application USD Million (2025-2030)
  • Table 200. Mexico Loratadine Syrup, by End User USD Million (2025-2030)
  • Table 201. Loratadine Syrup Sales: by Application(K Unit)
  • Table 202. Loratadine Syrup Sales Runny nose & Sneezing , by Region K Unit (2025-2030)
  • Table 203. Loratadine Syrup Sales Itchy, watery eyes , by Region K Unit (2025-2030)
  • Table 204. Loratadine Syrup Sales Itching of the nose or throat , by Region K Unit (2025-2030)
  • Table 205. Loratadine Syrup Sales: by End User(K Unit)
  • Table 206. Loratadine Syrup Sales Adults and Children 6 years of age and above , by Region K Unit (2025-2030)
  • Table 207. Loratadine Syrup Sales Children 2 to under 6 years of age , by Region K Unit (2025-2030)
  • Table 208. South America Loratadine Syrup Sales, by Country K Unit (2025-2030)
  • Table 209. South America Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 210. South America Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 211. Brazil Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 212. Brazil Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 213. Argentina Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 214. Argentina Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 215. Rest of South America Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 216. Rest of South America Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 217. Asia Pacific Loratadine Syrup Sales, by Country K Unit (2025-2030)
  • Table 218. Asia Pacific Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 219. Asia Pacific Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 220. China Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 221. China Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 222. Japan Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 223. Japan Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 224. India Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 225. India Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 226. South Korea Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 227. South Korea Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 228. Taiwan Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 229. Taiwan Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 230. Australia Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 231. Australia Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 232. Rest of Asia-Pacific Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 233. Rest of Asia-Pacific Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 234. Europe Loratadine Syrup Sales, by Country K Unit (2025-2030)
  • Table 235. Europe Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 236. Europe Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 237. Germany Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 238. Germany Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 239. France Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 240. France Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 241. Italy Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 242. Italy Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 243. United Kingdom Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 244. United Kingdom Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 245. Netherlands Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 246. Netherlands Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 247. Rest of Europe Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 248. Rest of Europe Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 249. MEA Loratadine Syrup Sales, by Country K Unit (2025-2030)
  • Table 250. MEA Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 251. MEA Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 252. Middle East Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 253. Middle East Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 254. Africa Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 255. Africa Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 256. North America Loratadine Syrup Sales, by Country K Unit (2025-2030)
  • Table 257. North America Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 258. North America Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 259. United States Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 260. United States Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 261. Canada Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 262. Canada Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 263. Mexico Loratadine Syrup Sales, by Application K Unit (2025-2030)
  • Table 264. Mexico Loratadine Syrup Sales, by End User K Unit (2025-2030)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Loratadine Syrup: by Application USD Million (2018-2023)
  • Figure 5. Global Loratadine Syrup: by End User USD Million (2018-2023)
  • Figure 6. South America Loratadine Syrup Share (%), by Country
  • Figure 7. Asia Pacific Loratadine Syrup Share (%), by Country
  • Figure 8. Europe Loratadine Syrup Share (%), by Country
  • Figure 9. MEA Loratadine Syrup Share (%), by Country
  • Figure 10. North America Loratadine Syrup Share (%), by Country
  • Figure 11. Global Loratadine Syrup: by Application K Unit (2018-2023)
  • Figure 12. Global Loratadine Syrup: by End User K Unit (2018-2023)
  • Figure 13. South America Loratadine Syrup Share (%), by Country
  • Figure 14. Asia Pacific Loratadine Syrup Share (%), by Country
  • Figure 15. Europe Loratadine Syrup Share (%), by Country
  • Figure 16. MEA Loratadine Syrup Share (%), by Country
  • Figure 17. North America Loratadine Syrup Share (%), by Country
  • Figure 18. Global Loratadine Syrup share by Players 2023 (%)
  • Figure 19. Global Loratadine Syrup share by Players (Top 3) 2023(%)
  • Figure 20. Global Loratadine Syrup share by Players (Top 5) 2023(%)
  • Figure 21. BCG Matrix for key Companies
  • Figure 22. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 24. Taro Pharmaceutical Industries Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Taro Pharmaceutical Industries Ltd. (United States) Revenue: by Geography 2023
  • Figure 26. Teva Pharmaceutical (Israel) Revenue, Net Income and Gross profit
  • Figure 27. Teva Pharmaceutical (Israel) Revenue: by Geography 2023
  • Figure 28. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 30. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 32. Sun Pharma (India) Revenue, Net Income and Gross profit
  • Figure 33. Sun Pharma (India) Revenue: by Geography 2023
  • Figure 34. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 35. Pfizer (United States) Revenue: by Geography 2023
  • Figure 36. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 37. Mylan (United States) Revenue: by Geography 2023
  • Figure 38. Global Loratadine Syrup: by Application USD Million (2025-2030)
  • Figure 39. Global Loratadine Syrup: by End User USD Million (2025-2030)
  • Figure 40. South America Loratadine Syrup Share (%), by Country
  • Figure 41. Asia Pacific Loratadine Syrup Share (%), by Country
  • Figure 42. Europe Loratadine Syrup Share (%), by Country
  • Figure 43. MEA Loratadine Syrup Share (%), by Country
  • Figure 44. North America Loratadine Syrup Share (%), by Country
  • Figure 45. Global Loratadine Syrup: by Application K Unit (2025-2030)
  • Figure 46. Global Loratadine Syrup: by End User K Unit (2025-2030)
  • Figure 47. South America Loratadine Syrup Share (%), by Country
  • Figure 48. Asia Pacific Loratadine Syrup Share (%), by Country
  • Figure 49. Europe Loratadine Syrup Share (%), by Country
  • Figure 50. MEA Loratadine Syrup Share (%), by Country
  • Figure 51. North America Loratadine Syrup Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bayer AG (Germany)
  • Taro Pharmaceutical Industries Ltd. (United States)
  • Teva Pharmaceutical (Israel)
  • Merck & Co., Inc. (United States)
  • Bayer AG (Germany)
  • Sun Pharma (India)
  • Pfizer (United States)
  • Mylan (United States)
Additional players considered in the study are as follows:
Sandoz (Switzerland) , Apotex (Canada) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 240 Pages 59 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Loratadine Syrup Market Quantitative research analysis
Global Loratadine Syrup Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bayer AG (Germany), Taro Pharmaceutical Industries Ltd. (United States), Teva Pharmaceutical (Israel), Merck & Co., Inc. (United States), Bayer AG (Germany), Sun Pharma (India), Pfizer (United States) and Mylan (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Continuous Development in Loratadine Drugs" is seen as one of major influencing trends for Loratadine Syrup Market during projected period 2023-2030.
The Loratadine Syrup market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Loratadine Syrup Market Report?

Have a Query? Click Here

Other Related Reports

Calcium Supplement Comprehensive Study by Type (Children, Adult, The Aged), Application (Nutraceutical and supplements, Calcium Deficiency, Fitness purpose), End Users (Pharmacy, Hospital, Online, Ot...
$ 3450
Autoimmune Drugs Comprehensive Study by Type (B cell inhibitors, T cell inhibitors, Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Immunosuppressants, Beta Interferons, Insulin, Others), A...
$ 3750
Video Cystoscopes Comprehensive Study by Type (Flexible Cystoscopy, Rigid Cystoscopy), Application (Hospitals, Ambulatory Surgical Centers, Others), Length (37 cm, 40 cm), Cystoscopes Ranges (14 F, 1...
$ 3800
Oral Antiplatelets Comprehensive Study by Type (Irreversible Cyclooxygenase Inhibitors , ADP Receptor Inhibitors , Phosphodiesterase Inhibitors), Application (Acute Coronary Syndrome, Post Percutaneo...
$ 3750
Genitourinary Drugs Comprehensive Study by Type (Urologicals, Hormonal Therapy, Gynecological, Anti-infectives), Drug Type (Hormonal Therapy, Targeted Drugs, Urinary Antispasmodics, Uterine relaxants...
$ 3750
Grass Pollen Allergy Drug Comprehensive Study by Type (BM-32, Pollinex Quattro Grass, Others), Application (Home Use, Hospital, Research Center) Players and Region - Global Market Outlook to 2027
$ 3500